TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05886959

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Session 1: How We Evolved - Threat, Impulse, and Soothing Systems
Description: The practice of Breath break with kindness will be applied for 5 minutes. Afterwards, 15 minutes of information on threats, impulses and soothing systems, A safe place application for 11 minutes, Courtesy meditation for 10 minutes. After each application, 10 minutes of feedback will be received from the participants.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Session 2: Threat and Self-Compassion
Description: The practice of breathing with kindness will be done for 7 minutes. The practice of Building a compassionate relationship with resilience will be held for 12 minutes, and the practice of Kindness meditation: a benevolent will take place for 11 minutes. A hand over your heart application will be made for 3 minutes and A compassionate comrade application will be done for 10 minutes. After each application, 3 minutes of feedback will be received from the participants.
Study: NCT06139822

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Control group included Cold pack for 7 to 10 mins. Followed by stretching of plantar fascia .
Study: NCT05886959

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Session 3: Unraveling the Knots of Desire and Patterns
Description: The practice of breathing with kindness will be done for 7 minutes. Building a compassionate relationship with desire 12 minutes, Guided meditation to discover the inner pattern 10 minutes and Courtesy meditation: a good friend 11 minutes. Except for the breath break with kindness application, 3 minutes of feedback will be received from the participants after each application

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Session 4: Internalizing compassion
Description: The pretend-to-be practice for the participants to observe themselves will be made for 10 minutes. The practice of internalizing compassion will be done for 7 minutes, kindness meditation: a neutral person practice for 10 minutes, and kindness towards your body for 10 minutes. After each application, 3 minutes of feedback will be received from the participants.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Session 5: Me and others - Expanding the circle
Description: The a compassionate letter practice with the participants will continue for 15 minutes. meditation: the 'difficult' person 8 minutes, compassion and breathing: yourself 10 minutes and compassionate breathing: others 7 minutes. A compassionate break application is performed for 7 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Session 6: Growing happiness
Description: The practice of Revisiting the good is carried out for 10 minutes with the participants. Forgive yourself, wish for forgiveness, forgive others, gratitude practices will be held for 5 minutes each and will take 20 minutes in total. Courtesy meditation: groups and all beings will be practiced for 10 minutes. After each application, 3 minutes of feedback will be received from the participants.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Session 7: Weaving Wisdom and Compassion into Daily Life
Description: Participants will be given 10 minutes to choose a day in their life and allow a few minutes to pause mindfully. The practice of a breather for wise and compassionate action is 10 minutes, the practice of calmness meditation is 8 minutes, and the practice of sharing the joy meditation is 8 minutes. After each application, 3 minutes of feedback will be received from the participants.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Session 8: Living with the Heart
Description: The participants are told about the applications they can apply for, where they need help to develop compassion towards self-healing skills, and the entire training will be evaluated for 20 minutes. The river of life application is carried out for 20 minutes. 10 minutes of feedback will be received after the application.
Study: NCT05885334

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 360 videos
Description: Caregivers will receive a educational solution of 360 degrees videos with care situations simulations for 1h. After six months, performance in caregivers tasks will be video recorded.
Study: NCT05387785

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANG-3070
Description: Orally administered tyrosine kinase inhibitor capsule.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ANG-3070
Description: Orally administered tyrosine kinase inhibitor capsule.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Orally administered placebo capsule

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Orally administered placebo capsule
Study: NCT05946096

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dynamic surface exercise training
Description: Dynamic surface exercise training involves a set of exercises that are performed on various dynamic surfaces like gym ball and vestibular swing. All these exercise provide optimal arousal as they provide proprioceptive and vestibular stimulus. This group received a set of exercises on various dynamic surfaces.These exercises were implemented for 60 minutes for four days a week for two months.And it was observed how these exercises impacted gross motor function and trunk control of children with diplegic cerebral palsy of GMFCS level 3 and 4

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional physical therapy
Description: conventional physical therapy based on NDT involves a set of exercises that mostly include positioning exercises such as quadruped, side sitting, reaching sideways and overhead in sitting and catch and throw activities.
Study: NCT04938726

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone Monoester
Description: Ketone supplement will be taken by mouth at a dose of 15 mL twice per day

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Ketone Monoester
Description: Ketone supplement will be taken by mouth at a dose of 15 mL twice per day
Study: NCT06538493

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: JUMPSTART-ANAI
Description: Patient questionnaire about experiences, preferences, and concerns regarding ACP followed by feedback form with tips for initiating ACP conversation with provider at next clinical visit.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: JUMPSTART-ANAI
Description: Patient questionnaire about experiences, preferences, and concerns regarding ACP followed by feedback form with tips for initiating ACP conversation with provider at next clinical visit.
Study: NCT06652880

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital technology
Description: The digital app is a customized comprehensive self-management platform designed to provide recovery and parenting support for individuals with substance use disorders.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bibliotherapy
Description: Bibliotherapy control group will receive parenting book what to expect the first year.
Study: NCT06650865

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Exercise Group
Description: It is important for the therapist to organize a exercise program to provide pain control. The exercise program should be specific and clear to the patient.~Exercises will be applied to this group. The exercise steps will be continued 3 days a week for 6 weeks. All scales and tests will be completed again at week 12 for long-term follow-up.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baduanjin Exercise Group
Description: In addition to the standard physical therapy program, Baduanjin will be applied for 30 minutes.~The exercise steps will be continued 3 days a week for 6 weeks. All scales and tests will be completed again at week 12 for long-term follow-up.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telerehabilitation Group
Description: Baduanjin exercise will be applied simultaneously with the telerehabilitation method. In addition to the standard physical therapy program, Baduanjin will be applied for 30 minutes.~The exercise steps will be continued 3 days a week for 6 weeks. All scales and tests will be completed again at week 12 for long-term follow-up.
Study: NCT06604806

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PENG Block
Description: With the patient in the supine position, the ultrasound probe is placed transversely over the anterior superior iliac spine (ASIS). After identifying the ASIS, the transducer is aligned with the pubic ramus and rotated approximately 45 degrees to become parallel to the inguinal crease. The transducer is moved medially until the anterior inferior iliac spine (AIIS), iliopubic eminence (IPE), and psoas tendon are clearly visualized as anatomical landmarks. After confirming the correct location with saline injection, 50 mg of 0.25% bupivacaine will be administered.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PENG Block
Description: With the patient in the supine position, the ultrasound probe is placed transversely over the anterior superior iliac spine (ASIS). After identifying the ASIS, the transducer is aligned with the pubic ramus and rotated approximately 45 degrees to become parallel to the inguinal crease. The transducer is moved medially until the anterior inferior iliac spine (AIIS), iliopubic eminence (IPE), and psoas tendon are clearly visualized as anatomical landmarks. After confirming the correct location with saline injection, 50 mg of 0.25% bupivacaine will be administered.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Quadro-Iliac plane block
Description: With the patient in the prone position, a low-frequency convex transducer (2-6 MHz) and a 22G x 100 mm peripheral nerve block needle (Stimuplex® Ultra 360®, B-Braun) will be used. The transducer will be placed transversely at the L3 level to identify the spinal processes, followed by lateral movement to visualize the transverse process within the erector spinae muscle. The transducer will then be rotated parasagittally and moved caudally to locate where the Quadratus Lumborum muscle (QLM) attaches to the iliac crest. After confirming the location with saline, 50 mg of 0.25% bupivacaine will be administered under the fascia of the QLM.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Quadro-Iliac plane block
Description: With the patient in the prone position, a low-frequency convex transducer (2-6 MHz) and a 22G x 100 mm peripheral nerve block needle (Stimuplex® Ultra 360®, B-Braun) will be used. The transducer will be placed transversely at the L3 level to identify the spinal processes, followed by lateral movement to visualize the transverse process within the erector spinae muscle. The transducer will then be rotated parasagittally and moved caudally to locate where the Quadratus Lumborum muscle (QLM) attaches to the iliac crest. After confirming the location with saline, 50 mg of 0.25% bupivacaine will be administered under the fascia of the QLM.
Study: NCT05531916

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pressurized gloves and foot caps
Description: Using pressurized gloves and foot caps in order to prevent chemotherapy-induced peripheral neuropathy (CIPN).
Study: NCT04732637

Intervention type: DIAGNOSTIC_TEST
Intervention: Test At Home's Proprietary Lollipop Buccal Cavity Swab
Description: Self-collected Test At Home's proprietary Lollipop Buccal Cavity Swab with VTM.

Intervention type: DIAGNOSTIC_TEST
Intervention: Test At Home's Proprietary Lollipop Buccal Cavity Swab
Description: Self-collected Test At Home's proprietary Lollipop Buccal Cavity Swab with VTM.
Study: NCT05151887

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle protein synthesis
Description: The meals contain a total of 0.45 g protein/kg body mass (36 g protein for an 80 kg person). To account for differences in body mass, the investigators will scale the meal content to ensure 0.45 g/kg body mass for different body mass ranges (i.e., 65-75 kg, 75-85 kg, etc.). As such, carbohydrate, fat, and total energy content of the meals will also be scaled to body mass. The test meals are composed out of regular whole food items which will be purchased from local shops. The muscle protein synthetic response following meal ingestion will be assessed by the use of stable isotope tracer methodology

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle protein synthesis
Description: The meals contain a total of 0.45 g protein/kg body mass (36 g protein for an 80 kg person). To account for differences in body mass, the investigators will scale the meal content to ensure 0.45 g/kg body mass for different body mass ranges (i.e., 65-75 kg, 75-85 kg, etc.). As such, carbohydrate, fat, and total energy content of the meals will also be scaled to body mass. The test meals are composed out of regular whole food items which will be purchased from local shops. The muscle protein synthetic response following meal ingestion will be assessed by the use of stable isotope tracer methodology
Study: NCT06231992

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: opioid anaesthesia
Description: I.V Fentanyl (1-2ug/kg) before induction of general anesthesia with I.V propofol (1-2mg/kg), atracurium (0.5mg/kg). Intermittent boluses of fentanyl will be given intraoperatively when needed to maintain the change in hemodynamics within 20 % of the baseline.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Opioid free anaesthesia
Description: * IV Ketamine (0.25-0.5 mg/kg) before induction of general anesthesia with I.V propofol (1-2 mg/kg), atracurium (0.5mg/kg) followed by(0.25mg /min) infusion of ketamine for maintenance~* Dexamethasone I.V (8 mg) will be given before induction of general anesthesia.~* magnesium sulphate (20 mg/kg)in 100ml saline within 10 mints Followed by infusion of magnesium sulphate at rate of (10mg/kg/h).
Study: NCT04922606

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: US ot the GSV
Description: Ultrasound of the Great Saphenous Vein
Study: NCT04701190

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Noradrenalin 10 microgram bolus
Description: The noradrenaline bolus dosage of 10 microgram will be administered to the patient at the same time of obtaining cerebrospinal fluid running freely.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Noradrenaline 5 microgram bolus
Description: The noradrenaline bolus dosage of 5 microgram will be administered to the patient at the same time of obtaining cerebrospinal fluid running freely.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Noradrenaline 0.1 microgram/kg/minute infusion
Description: Infusion dosage: 0.1 microgram/kg/minute After the end of the injection of heavy marcaine 0.5% to the subarachnoid space, the infusion of noradrenaline with a 0.1 microgram/kg/minute dosage will be started.~Noradrenaline will be continued until 5 minutes after delivery of fetus.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Noradrenaline 0.05 microgram/kg/minute infusion
Description: Infusion dosage: 0.05 microgram/kg/minute After the end of the injection of heavy marcaine 0.5% to the subarachnoid space, the infusion of noradrenaline with a 0.05 microgram/kg/minute dosage will be started.~Noradrenaline will be continued until 5 minutes after delivery of fetus.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Infusion dosage: 0.075 microgram/kg/minute infusion
Description: nfusion dosage: 0.075 microgram/kg/minute After the end of the injection of heavy marcaine 0.5% to the subarachnoid space, the infusion of noradrenaline with a 0.075 microgram/kg/minute dosage will be started.~Noradrenaline will be continued until 5 minutes after delivery of fetus.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal anesthesia
Description: Spinal anesthesia using 0.5% 10 milligram heavy bupivacaine plus 12.5 microgram fentanyl

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal anesthesia
Description: Spinal anesthesia using 0.5% 10 milligram heavy bupivacaine plus 12.5 microgram fentanyl

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal anesthesia
Description: Spinal anesthesia using 0.5% 10 milligram heavy bupivacaine plus 12.5 microgram fentanyl
Study: NCT06415643

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Islet organoids transplantation
Description: autologous transplantation of ex vivo expanded islet organoids.
Study: NCT05262205

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: measuring depth of anesthesia and its relation to the globe
Description: measuring feasibility of BIS monitor in detecting depth of anesthesia in pediatric population and whether it will be beneficial as a tool for helping anesthesiologist in maintaining central globe alignment

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: measuring depth of anesthesia and its relation to the globe
Description: measuring feasibility of BIS monitor in detecting depth of anesthesia in pediatric population and whether it will be beneficial as a tool for helping anesthesiologist in maintaining central globe alignment
Study: NCT05564663

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PTSD Coach App + Brief Support
Description: PTSD Coach App + Brief Support will include downloading the PTSD Coach App for personal use and four, brief (\<20 minutes), weekly, individual support sessions. The sessions will focus on the instruction and encouragement of App use and activities (i.e., assessments, self-management strategies, and psychoeducational readings).

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Description: EUC will consist of one brief session (with brochure) of PTSD and AUD psychoeducation and referral information for mental health clinics that provide PTSD services, with encouragement to schedule an appointment at one of the listed clinics to discuss PTSD-related symptoms.
Study: NCT05254795

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Molecular tumor board assisted care
Description: Participants in this group will obtain recommendations for care from the molecular tumor board.
Study: NCT05232604

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Description: 30-45 minutes of aerobic exercise in a cycle ergometer will be applied in three different intensities (low, moderate and high) along 12 weeks of treatment.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neck motor control exercise
Description: An specific neck motor control exercise targeted to the neck flexor and extensor muscles supervised by a physical therapist will be applied during 12 weeks of treatment.
Study: NCT05444374

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Serplulimab
Description: Recombinant anti-PD-1 humanized monoclonal antibody injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Humanized anti-VEGF monoclonal antibody injection
Study: NCT06062147

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Teacher training
Description: Training for teachers in the intervention arm in the learning process, SLLD and early warning signs, with an identification grid. Observation of identified pupils and implementation of educational and environmental adjustments.
Study: NCT05756101

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Research on the application of novel restraint devices in postoperative patient safety management in cardiac surgery
Description: According to the individual characteristics of ICU patients and the needs of patients, a new type of restraint device was innovatively made and the effectiveness and safety of the new restraint device were studied, which provided clinical reference and theoretical basis for standardizing postoperative patient restraint.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Research on the application of novel restraint devices in postoperative patient safety management in cardiac surgery
Description: According to the individual characteristics of ICU patients and the needs of patients, a new type of restraint device was innovatively made and the effectiveness and safety of the new restraint device were studied, which provided clinical reference and theoretical basis for standardizing postoperative patient restraint.
Study: NCT04195334

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: internal fixation by IMN
Description: using retrograde or antegrade IMN for femooral fractures fixation using a fit nail to the femoral intramedullary canaland follow up for union
Study: NCT05574673

Intervention type: OTHER
Intervention: Standard of care
Description: Patients receive standard of care treatment according to local and national guidelines
Study: NCT06127862

Intervention type: OTHER
Group type: OTHER
Intervention: Education group
Description: Students in the experimental group were educated about environmental health and microplastica, and nursing interventions were made. The training was organized for twenty minutes in each session, with a total of four sessions at two-week intervals.

Intervention type: OTHER
Group type: OTHER
Intervention: No training was given
Description: No training was given
Study: NCT06181552

Intervention type: DIAGNOSTIC_TEST
Intervention: fundus photograpgy
Description: All the participants will undergo fundus photography.

Intervention type: DIAGNOSTIC_TEST
Intervention: fundus photograpgy
Description: All the participants will undergo fundus photography.

Intervention type: DIAGNOSTIC_TEST
Intervention: optical coherence tomography
Description: All the participants will undergo OCT examination.

Intervention type: DIAGNOSTIC_TEST
Intervention: optical coherence tomography
Description: All the participants will undergo OCT examination.

Intervention type: DIAGNOSTIC_TEST
Intervention: optical coherence tomography angiography
Description: All the participants will undergo OCT-A examination.

Intervention type: DIAGNOSTIC_TEST
Intervention: optical coherence tomography angiography
Description: All the participants will undergo OCT-A examination.
Study: NCT06326346

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liporaxel
Description: Liporaxel 200mg/m2 twice daily orally on day 1, 8, and 15 every 4 weeks (1 cycle = 4 weeks)
Study: NCT05443256

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Magnetic Stimulation
Description: Figure 8 coil stimulation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: Figure 8 coil stimulation
Study: NCT04537026

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amniotic Fluid Allograft
Description: Amniotic Fluid Allograft will be mixed with sterile water and injected using transforaminal approach

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone sodium phosphate
Description: Dexamethasone phosphate mixed with sterile water will be injected by transforaminal approach
Study: NCT04395196

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Choline bitartrate
Description: Provided in beverage form

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Provided in beverage form